Thus, the clinicopathological features of low tumor T cell infiltration, low PD-1 T cell and PD-L1 expression, insufficient neoantigens and low mutational burden as well as the absence of IFN-γ signaling have been linked to a primary resistance to checkpoint inhibition (222). This evidence concerns the gene IFNG and neoplasm.